Home › Funds › Polaris Capital Management, LLC › UTHR

Polaris Capital Management, LLC position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

Polaris Capital Management, LLC reported holding 48,950 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$26.5M, representing 2.78% of its reported portfolio and ranking #10 among its reported holdings. Polaris Capital Management, LLC has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)48.95K sh
Reported value held$26.53M
Portfolio Weight2.78%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Polaris Capital Management, LLC's UTHR position evolved

Polaris Capital Management, LLC first disclosed a stake in UTHR in Q3 2023 at 134,550 shares (US$30.4M). The position peaked in Q1 2026 at 96,650 shares, worth US$57.3M. Across 13 filings, Polaris Capital Management, LLC increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 48,950 shares valued at US$26.5M — a reduction of -4,500 shares quarter over quarter.. Notable position changes include a 45% trim in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 134.55K $30.39M New
Q4 2023 142.55K $31.35M Add
Q1 2024 129.95K $29.85M Reduce
Q2 2024 148.55K $47.32M Add
Q3 2024 141.95K $50.87M Reduce
Q4 2024 131.85K $46.52M Reduce
Q1 2025 137.05K $42.25M Add
Q2 2025 127.65K $36.68M Reduce
Q3 2025 122.05K $51.16M Reduce
Q4 2025 103.65K $50.50M Reduce
Q1 2026 96.65K $57.31M Reduce
Q2 2026 53.45K $28.96M Reduce
Q3 2026 48.95K $26.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 39 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has Polaris Capital Management, LLC held UTHR?

Polaris Capital Management, LLC has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Polaris Capital Management, LLC's current position in UTHR?

As of Q3 2026, Polaris Capital Management, LLC holds 48.95K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $26.53M, representing 2.78% of its reported portfolio and ranking #10.

Has Polaris Capital Management, LLC been buying or selling UTHR?

In the latest 13F filing (Q3 2026), Polaris Capital Management, LLC reduced its position in UTHR. The position peaked in Q1 2026 at 96.65K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.